UPDATE : Wednesday, September 18, 2019
상단여백
Korean pharmaceuticals challenge Pfizer’s Viviant with combination drugs by Lee Hye-seon 2017-09-18 11:26
HIRA’s drug pricing allegedly favors Green Cross, PMG Korea by Song Soo-youn 2017-09-15 17:58
Kolon uses Invossa to attract foreign patients by Lee Hye-seon 2017-09-15 17:49
SK Chemicals’ release of test result abroad raises curiosity by Lee Hye-seon 2017-09-15 17:39
Hanmi releases research result of new bio drug in Europe by Lee Hye-seon 2017-09-15 14:32
라인
LG Chem promotes antidiabetic Zemiglo in Europe by Lee Hye-seon 2017-09-15 11:51
In historic move, FDA approves 1st biosimilar to treat cancer by Marian Chu 2017-09-15 11:40
Huons to build new office by Lee Han-soo 2017-09-15 10:29
Daewoong wins rights to market hepatitis B treatment by Constance Williams 2017-09-14 19:37
NOAC race: Pradaxa prescription numbers fall behind fast followers by Marian Chu 2017-09-14 19:02
라인
Opdivo vs. Keytruda - which will doctors choose? by Marian Chu 2017-09-14 17:54
Chong Kun Dang enters an osteoporosis therapy market by Lee Hye-seon 2017-09-14 17:53
AstraZeneca regains momentum with positive Imfinzi results by Marian Chu 2017-09-14 13:34
Amgen, Chong Kun Dang to sell osteoporosis drug in Korea by Marian Chu 2017-09-13 18:33
Alvogen Korea to sell Vivus’ obesity drug by Marian Chu 2017-09-13 18:16
라인
ASEAN officials visit JW’s manufacturing plant by Song Soo-youn 2017-09-13 18:07
Opdivo’s expanded indications ease cancer patients’ worries by Marian Chu 2017-09-13 16:57
Anticoagulant drugs will add SJS Warning by Lee Hye-seon 2017-09-13 15:55
Brokerage analyzes profit-sharing structure of Celltrion group by Nam Doo-hyun 2017-09-12 16:55
EU approves Abbvie’s Humira as first biologic to treat CHMP by Marian Chu 2017-09-12 15:45
여백
여백
여백
Back to Top